• Join
  • Login
  • Contact

Search abstracts

Quality by design - implications for drug development and manufacture

  • In: D18 - Good Manufacturing Practices - Expectations for the coming decade (part II) on Thursday, 8 September 2011, 14:00-17:00
  • At: Hyderabad (India) (2011)
  • Type: Presentation
  • By: SAM, Tom (MSD, Oss, Netherlands)
  • Abstract:

    The introduction of Quality by Design has transformed in the past 5 years the way we think about drug development and manufacture to an extent that we even speak about a paradigm shift. We now all know that drugs should be developed science and risk based rather than by traditional approaches. Be it true in theory, in practice still many companies


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses